Evidence map›Paper›PMID 20178593›Full record

ArticleBMC medical genomics2010

Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study.

Marjan J van Erk, Suzan Wopereis, Carina Rubingh, Trinette van Vliet, Elwin Verheij, Nicole H P Cnubben, Theresa L Pedersen, John W Newman, Age K Smilde, Jan van der Greef and 2 more

Registry-linked trialOpen access · goldAbstract readControlled Clinical Trial
In one paragraph

Article in BMC medical genomics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00221052 (Relation Between Reduction of the Inflammatory Status and Glucose Metabolism in Healthy Overweight Men), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00221052 nacompletednot on this map

Relation Between Reduction of the Inflammatory Status and Glucose Metabolism in Healthy Overweight Men

TypeinterventionalSponsorTNORan2005 to 2005Enrolled20ConditionsOverweight, Obesity, InflammationArmsDiclofenac
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. The value of an ecological approach to address micronutrient malnutrition.The American journal of clinical nutrition · 2025
    Article
  7. Review
  8. The Immune Response of Cancer Cells in Breast and Gynecologic Neoplasms.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Inflammatory mechanisms linking obesity and tendinopathy.Journal of orthopaedic translation · 2021
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Observational
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Marjan J van ErkTNO Quality of Life, PO Box 360, 3700 AJ Zeist, the Netherlands. marjan.vanerk@tno.nl
Suzan Wopereis
Carina Rubingh
Trinette van Vliet
Elwin Verheij
Nicole H P Cnubben
Theresa L Pedersen
John W Newman
Age K Smilde
Jan van der Greef
Henk F J Hendriks
Ben van Ommen
Pension Fund for Care and Well-Being · NLNetherlands Institute for Neuroscience · NLUniversity of California, Davis · USWestern Human Nutrition Research Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic systemic low-grade inflammation in obese subjects is associated with health complications including cardiovascular diseases, insulin resistance and diabetes. Reducing inflammatory responses may reduce these risks. However, available markers of inflammatory status inadequately describe the complexity of metabolic responses to mild anti-inflammatory therapy.

methodsTo address this limitation, we used an integrative omics approach to characterize modulation of inflammation in overweight men during an intervention with the non-steroidal anti-inflammatory drug diclofenac. Measured parameters included 80 plasma proteins, >300 plasma metabolites (lipids, free fatty acids, oxylipids and polar compounds) and an array of peripheral blood mononuclear cells (PBMC) gene expression products. These measures were submitted to multivariate and correlation analysis and were used for construction of biological response networks.

resultsA panel of genes, proteins and metabolites, including PGE2 and TNF-alpha, were identified that describe a diclofenac-response network (68 genes in PBMC, 1 plasma protein and 4 plasma metabolites). Novel candidate markers of inflammatory modulation included PBMC expression of annexin A1 and caspase 8, and the arachidonic acid metabolite 5,6-DHET.

conclusionIn this study the integrated analysis of a wide range of parameters allowed the development of a network of markers responding to inflammatory modulation, thereby providing insight into the complex process of inflammation and ways to assess changes in inflammatory status associated with obesity.

trial registrationThe study is registered as NCT00221052 in clinicaltrials.gov database.

Indexed as

AdultAnnexin A1Anti-Inflammatory Agents, Non-SteroidalBody Mass IndexCaspase 8DiclofenacDinoprostoneGene Expression ProfilingHumansInflammationInflammation MediatorsMaleMetabolomicsMiddle AgedMultivariate AnalysisObesityAnnexin A1Anti-Inflammatory Agents, Non-SteroidalCaspase 8DiclofenacDinoprostoneInflammation MediatorsTumor Necrosis Factor-alpha

Identifiers

PMID20178593
PMCPMC2837611
OpenAlexW2161607547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.